asa guidelines for glp 1 drugs Glucagon-Like Peptide Receptor Agonists and Aspiration Risk GLP-1 RA guidance roundup -
Description
After screening by title and abstract, 16 articles were available to be assessed in full-text screening
Across all GLP-1 RAs studied, 6.6% of patients switched to a different drug at least once in a subsequent month during JanuaryJuly 2025
The severity of nausea can vary depending on the person
The breakdown shows 14.3% of patients have minimal retention, 44.3% show moderate amounts, and 41.4% have large quantities [3]
Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: a randomized, placebo-controlled, double-blind, crossover trial
